Who is rani therapeutics llc? Imran and Daniel H. Kim in 2004 and is headquartered in St. Paul, MN. Rani Therapeutics LLC develops a oral biotherapeutics technology for the oral delivery of drug molecules, including peptides, proteins, and antibodies. Its products include TNFa Inhibitors, Parathyroid Hormone, Human Growth Hormone, Somatostatin, and Basal Insulin.What is the rani platform? Rani Therapeutics has developed a disruptive technology for the oral delivery of biologics including peptides, proteins and antibodies. Delivery Equivalent to Subcu Injections. We have tested the Rani platform with several molecules.Who is the ceo of rani technologies? Talat was appointed CEO in June 2021. Talat has been a key member of Rani’s executive team, most recently serving as the company’s Vice President, Strategy since 2014. In addition to his role at Rani, Talat has been a venture capitalist with several healthcare-focused Silicon Valley funds, including InCube Ventures, LP, and VentureHealth.How does the ranipill work? The RaniPill ™ capsule is swallowed by the patient and makes its way past the stomach to the intestine. Once the RaniPill ™ capsule reaches the intestine, it activates revealing the delivery mechanism. The drug is absorbed with bioavailability similar to a subcutaneous injection.
Rani Therapeutics LLC is a Texas Foreign Limited-Liability Company (Llc) filed On November 8, 2021. The company's filing status is listed as In Existence and its File Number is 0804304663. The Registered Agent on file for this company is CT Corporation System and is located at 1999 Bryan Street, Suite 900, Dallas, TX 75201.